Substances
Eszopiclone: Long-Term Use vs Short-Term Use for Insomnia
Medically Reviewed By
Written By
Last medically reviewed : June 16, 2025
Updated On : June 16, 2025
Good sleep is essential for overall well-being. In fact, it’s considered one of the three pillars of health, alongside movement and nutrition.[1] Unfortunately, as important as sleep is, achieving it can be difficult for some. Currently, one in three adults fails to get a good night’s sleep, and 12% of Americans have trouble falling or staying asleep.[2] This is called insomnia.[3]
Insomnia causes individuals to experience various physical and mental health challenges and can deteriorate their quality of life without treatment. One such treatment is eszopiclone, also known as Lunesta.
In this blog post, you will learn about Lunesta, its short-term and long-term effects, and whether or not using it leads to addiction.
Insomnia is a sleep disorder that makes falling or staying asleep difficult. It is usually an ongoing problem that affects sleep and how you function when awake.[4] There are two forms of insomnia: acute and chronic.[4]
Insomnia has many causes that range from poor lifestyle choices to chronic health conditions.
Other causes include, but are not limited to:[4]
Insomnia risk factors encompass older age, lack of physical activity, mental distress, stressful jobs, and African-American ethnicity.
You might have insomnia if you have experienced:[4]
Untreated insomnia can lead to health conditions like high blood pressure, heart disease, and diabetes. It can also affect your mental health, energy, and cognitive function.
Traditionally, benzodiazepines were used to treat sleep disorders like insomnia.[5] However, medications in this class of drugs carry a high potential for abuse and dependence. Eszopiclone (Lunesta), on the other hand, is a nonbenzodiazepine that carries the same hypnotic properties, making it a safer alternative for those who wish to avoid more addictive treatments.[6]
Lunesta gained FDA approval in 2004 for the treatment of insomnia. However, a number of potential off-label uses have been observed in clinical practice.
They include:
Even with a low risk for dependency, taking Lunesta for a reason other than prescribed can significantly enhance this risk.
Eszopiclone works by interacting with GABA receptors in the brain.[11] This slows brain activity and promotes restful sleep. Its effects begin rapidly after taking an initial 3 mg dose.[12] The medication is quickly absorbed in tissues throughout the body, including the brain, with peak plasma concentration within 1-1.6 hours.[12]
Due to the way Lunesta interacts with GABA A receptors in the brain, using it can cause side effects like:[13]
Some Lunesta users may experience serious side effects, including:[13]
If you develop any of the above-listed symptoms, discuss them with your doctor. Do not stop taking Lunesta without first checking with your doctor. Stopping it suddenly can lead to withdrawal symptoms.[13]
A black box warning is the most serious warning the U.S. Food and Drug Administration issues for medications. According to StatPearls, these warnings are intended to draw the consumer’s attention to the medication’s major risks.[14]
Lunesta received a black box warning from the FDA on April 30, 2019, for complex sleep behaviors resulting in serious injuries or death.[15] They can occur even at the lowest recommended dose or after just one dose.
According to the FDA, healthcare professionals should not prescribe Lunesta to patients who have previously experienced complex sleep behaviors after taking a sleep aid.[15] Although occurrences of complex sleep behaviors are rare, patients should stop taking this medication if they experience one, including:[15]
Based on clinical evidence, Lunesta is generally well tolerated.[16] However, this doesn’t mean there aren’t long-term effects of using the medication. This drug is habit-forming, and long-term use has been associated with a higher risk of developing a physical dependence.[17] For this reason, some physicians are reluctant to prescribe it as a long-term solution for chronic insomnia and opt instead for a non-habit-forming alternative.
Other long-term effects associated with eszopiclone use include:
It’s important to note that clinical trials revealed no evidence of serious withdrawal syndrome in Lunesta users. However, adverse events were reported within the first 48 hours.[20]
According to the U.S. Food and Drug Administration, symptoms of Lunesta withdrawal are similar to those of other CNS depressants.[20]
They include, but are not limited to:[22]
To prevent these symptoms, the prescribing physician will gradually decrease the dose until reaching the minimal effective dosage.[23] A common tapering schedule involves reducing the dose by 25% each week. This tapering dose may be adjusted based on the patient’s withdrawal symptoms.[23]
Short-term effects linked to Lunasa typically subside once the medication is fully eliminated from the system. Since it has a mean elimination half-life of six hours, it would take approximately 30 to 36 hours for most of these effects to dissipate.[24]
Common short-term effects include:[24]
Abnormal thinking behaviors have been observed in individuals who take Lunesta, no matter the dosage or duration used.[25] If you experience an increase in agitation, depression, or anxiety, or you have new or worsening suicidal thoughts, contact your prescriber immediately.
Yes, Lunesta has been given a controlled substance designation by the United States Drug Enforcement Agency.[26] It is listed as a Schedule IV Controlled Substance due to its risk for misuse and abuse.[26] While this risk remains relatively low for individuals who use the medication short-term and as prescribed, studies indicate a potential for dependency due to misuse or concurrent drug use.
Yes. Although Lunesta is FDA-approved for both short-term and long-term treatment of insomnia, long-term use has been linked to a higher prevalence of physical dependency and abuse. However, AccessFDA states that the risk of dependency is relatively low for Lunesta when compared to sleep aids with benzodiazepine properties, such as Ambien.[20]
People who become dependent on hypnotic drugs like Lunesta do so as a result of drug tolerance. This means over time, their bodies adjust to the medication in a way that requires higher doses to achieve the original effect. Although the risk of dependence is relatively low with Lunesta, taking it in a way other than prescribed can significantly increase this risk. Combining Lunesta with alcohol or other CNS depressant drugs can also lead to dependence and addiction.[20]
Signs of Lunesta dependence include:
As noted by Harvard Health, no specific dosage or daily pill count definitively indicates dependence on a hypnotic medication.[27]
Addiction is defined as a relapsing disorder characterized by compulsive drug seeking and drug use. When taken as prescribed, Lunesta rarely leads to addiction. However, using more than prescribed, for longer than prescribed, or in any way other than prescribed is considered misuse and can lead to addiction.[28]
According to the Diagnostic and Statistical Manual V (DSM-5), a person must acknowledge two or more of the following 11 criteria to have an addiction:[29]
Although addiction is not curable, it is a treatable disorder. According to the National Institute on Drug Abuse, the principles of an effective addiction treatment plan include detoxing with or without medication combined with behavioral therapy or counseling.[30]
Behavioral therapy helps patients identify, avoid, and cope with situations that trigger drug abuse.[30] It is an action-based therapy, which requires the participant to make attainable incremental changes to reach their goal of full recovery. Some forms of behavior therapy engage in contingency management. This form of therapy uses positive reinforcement, such as rewards or other incentives for remaining substance free, attending counseling sessions, or participating in group activities.
If you feel you have a dependence on Lunesta, bring this up to your healthcare provider. The sooner you begin a recovery plan, the sooner you regain control over your life.
Are you or someone you know struggling with Lunesta addiction? We’re here to help! Contact Engage Wellness today for a confidential consultation to find out how we can help you reach full recovery.
Eszopiclone, also called Lunesta, is a non-benzodiazepine hypnotic used to treat insomnia. Like other sleep aids in the hypnotic category, eszopiclone slows activity in the central nervous system (CNS), helping the user fall asleep faster and stay asleep longer.
As a non-benzodiazepine, eszopiclone has a lower risk for addiction than sleep aids in the benzodiazepine category. However, using it in a way other than prescribed can increase the risk of dependency and, in turn, addiction.
Misusing or taking abusive doses of eszopiclone can lead to changes in the brain that can be long-lasting. These changes may cause the user to experience physical symptoms during periods of abstinence.
The U.S. Food and Drug Administration (FDA) issued a warning to Lunesta users regarding its potential to cause severe decreased mental alertness and next-day impairment.
Yes, there are a number of alternatives to Lunesta that are helpful in treating insomnia. They include Ambien (zolpidem), Sonata, and Restoril (temazepam).
[1] American Sleep Apnea Association. (n.d.). The State of Sleep Health in America 2023. Retrieved from https://www.sleephealth.org/sleep-health/the-state-of-sleephealth-in-america/ on 2025 May 14.
[2] American Academy of Sleep Medicine. (2024 Jun 14). Survey Shows 12% of Americans Have Been Diagnosed with Chronic Insomnia. Retrieved from https://aasm.org/survey-shows-12-of-americans-have-been-diagnosed-with-chronic-insomnia/ on 2025 May 14.
[3] National Heart, Lung and Blood Institute. (2022 Mar 24). Insomnia: What is Insomnia? Retrieved from https://www.nhlbi.nih.gov/health/insomnia on 2025 May 14.
[4] UCLA Health. (2024 Jul 22). Can’t sleep? What You Need to Know About Insomnia. Retrieved from https://www.uclahealth.org/news/article/cant-sleep-what-you-need-know-about-insomnia on 2025 May 14.
[5] Stanford Medicine. (n.d.). Treating Insomnia with Medications. Retrieved from https://stanfordhealthcare.org/medical-conditions/sleep/insomnia/treatments/treating-insomnia-with-medications.html on 2025 May 14.
[6] National Library of Medicine. (2018 Oct 12). Eszopiclone for Insomnia. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6492503/ on 2025 May 14.
[7] National Library of Medicine. (2012 Aug 25). Strategies for the Treatment of Restless Leg Syndrome. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3480566/ on 2025 May 14.
[8] National Library of Medicine. (2011 Jun 26). Effects of Eszopiclone and zolpidem on Sleep-wake Behavior, Anxiety-like Behavior and Contextual Memory in Rats. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2844486/ on May 15.
[9] National Library of Medicine. (2010 Nov 30). Effect of Eszopiclone on Sleep, Fatigue, and Pain in Patients with Mucositis Associated with Hematologic Malignancies. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3204044/ on 2025 May 15.
[10] National Library of Medicine. (2022 Nov). Study of the Real Situation of Improvement by Zopiclone in Treatment of Insomnia among Persons Working During Night Shifts. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12451343/ on 2025 May 15.
[11] Drugs.com (2024 Nov 7). Eszopiclone Information. Retrieved from https://www.drugs.com/eszopiclone.html on 2025 May 15.
[12] National Library of Medicine. (2007 Aug 3). Eszopiclone: Its Use in the Treatment of Insomnia. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2655082/ on 2025 May 14.
[13] Drugs.com. (2025 Apr 14). Eszopiclone Side Effects. Retrieved from https://www.drugs.com/sfx/eszopiclone-side-effects.html on 2025 May 14.
[14] Stat Pearls. (2023 Jun 7). Box Warnings. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK538521/ on 2025 May 14.
[15] U.S. Food and Drug Administration (FDA). (2019 Apr 30). FDA Adds Boxed Warning for Risk of Serious Injuries Caused by Sleepwalking with Certain Prescription Insomnia Medicines. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia on 2025 May 14.
[16] National Library of Medicine. (2007 Aug 3). Eszopiclone: Its Use in the Treatment of Insomnia. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2655082/ on 2025 May 14.
[17] Drugs.com (2024 Nov 8). Why is Lunesta (Eszopiclone) a Controlled Substance? Retrieved from https://www.drugs.com/medical-answers/why-lunesta-eszopiclone-controlled-substance-3578420/ on 2025 May 14.
[18] Drugs.com (2024 Nov 7). Lunesta: Uses, Dosage, and Side Effects. Retrieved from https://www.drugs.com/lunesta.html on 2025 May 14.
[19] U.S. Food and Drug Administration. (2014 May 15). FDA Drug Safety Communication: FDA Warns of Next-Day Impairment with Sleep Aid Lunesta (Eszopiclone) and Lowers Recommended Dose. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-next-day-impairment-sleep-aid-lunesta-eszopiclone-and-lowers on 2025 May 14.
[20] AccessData FDA. (2019 Aug 18). Lunesta Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf on 2025 May 14.
[21] National Library of Medicine. (2010 Aug). The Definition of Drug Dependence. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20715472/ on 2025 May 14.
[22] National Library of Medicine. (2019 Oct 16). Dependence, Withdrawal and Rebound of CNS Drugs: An Update and Regulatory Considerations for New Drug Development. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7425303/ on 2025 May 14.
[23] National Library of Medicine. (2009 Dec 10.) Management of Hypnotic Discontinuation in Chronic Insomnia. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2896266/ on 2025 May 14.
[24] U.S. Food and Drug Administration (FDA). (2018 Nov). Lunesta Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021476s036lbl.pdf on 2025 May 14.
[25] New Scientist. (2007 Feb 6). Sleep Medication Linked to Bizarre Behaviour. Retrieved from https://www.newscientist.com/article/dn11115-sleep-medication-linked-to-bizarre-behaviour/ on 2025 May 14.
[26] United States Drug Enforcement Administration (DEA). (n.d.). Drug Scheduling. Retrieved from https://www.dea.gov/drug-information/drug-scheduling on 2025 May 14.
[27] Harvard Health Publishing. (2022 Feb 8). Sedative, Hypnotic or Anxiolytic Drug Use Disorder. Retrieved from https://www.health.harvard.edu/a_to_z/sedative-hypnotic-or-anxiolytic-drug-use-disorder-a-to-z on 2025 May 14.
[28] National Institute of Drug Abuse. (2020 Jul). Drug Misuse and Addiction. Retrieved from https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/drug-misuse-addiction on 2025 May 14.
[29] Door County Wisconsin. (n.d.). Criteria for Substance Use Disorders DSM-5. Retrieved from https://www.co.door.wi.gov/DocumentCenter/View/2533/Criteria-for-Substance-Use-Disorders-PDF on 2025 May 14.
[30] National Institute of Drug Abuse. (2020 Jul). Drugs, Brains, and Behavior: The Science of Addiction. Retrieved from https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery on 2025 May 14.